OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder
Alladi Charanraj Goud, Bruno Étain, Frank Bellivier, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3026-3026
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Dissecting major depression: The role of blood biomarkers and adverse childhood experiences in distinguishing clinical subgroups
Luisa Lo Iacono, Silvia Bussone, Diego Andolina, et al.
Journal of Affective Disorders (2020) Vol. 276, pp. 351-360
Closed Access | Times Cited: 15

The “missing heritability”—Problem in psychiatry: Is the interaction of genetics, epigenetics and transposable elements a potential solution?
Dietrich van Calker, Tsvetan Serchov
Neuroscience & Biobehavioral Reviews (2021) Vol. 126, pp. 23-42
Open Access | Times Cited: 14

Epigenetic Signatures in Hypertension
Gerardo Alfonso, Victor Delgado Martinez
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 787-787
Open Access | Times Cited: 5

Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review
Manuel Gardea-Reséndez, Mehmet Utku Küçüker, Caren J. Blacker, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 14

The Global Socioeconomic Impact of Mental Health
Raphael Louis
SocioEconomic Challenges (2022) Vol. 6, Iss. 2, pp. 50-56
Open Access | Times Cited: 7

Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder
Kyle J. Burghardt, Bradley H. Howlett, Elani Sanders, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 12, pp. 1365-1373
Open Access | Times Cited: 7

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder
Héctor J. Caruncho, Tania Rivera‐Baltanás, Raquel Romay-Tallón, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 6

DDR1 methylation is associated with bipolar disorder and the isoform expression and methylation of myelin genes
Beatriz García-Ruiz, Manuel Castro de Moura, Gerard Muntané, et al.
Epigenomics (2021) Vol. 13, Iss. 11, pp. 845-858
Closed Access | Times Cited: 6

Tet Enzyme-Mediated Response in Environmental Stress and Stress-Related Psychiatric Diseases
Meiling Xia, Rui Yan, Myoung‐Hwan Kim, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 3, pp. 1594-1608
Closed Access | Times Cited: 3

DNA methylation differences in genes associated with human personal disorders and deviant behavior
И. Б. Моссэ, Nikita Sedlyar, К. А. Моссэ, et al.
AIMS neuroscience (2024) Vol. 11, Iss. 1, pp. 39-48
Open Access

Systemic inflammation, oxidative damage and neurocognition predict telomere length in a transdiagnostic sample stratified by global DNA methylation levels
Joan Vicent Sánchez‐Ortí, Patricia Correa‐Ghisays, Vicent Balanzá‐Martínez, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Mental Disorders and DNA Methylation
Seda Örenay-Boyacıoğlu, Olcay Boyacıoğlu, Ayşe Döndü
Springer eBooks (2024), pp. 1-23
Closed Access

NRN1 genetic variability and methylation changes as biomarkers for cognitive remediation therapy response in schizophrenia
Carmen Almodóvar-Payá, Irene París-Gómez, Mariona Latorre-Guardia, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111175-111175
Closed Access

Disease Biomarker Discovery
Tikam Chand Dakal, Alisha Kumar, Alisha Parveen
Elsevier eBooks (2024)
Closed Access

Therapeutic potential of cannabidiol in depression
Matti Bock Guldager, Adriano Maia Chaves Filho, Caroline Biojone, et al.
International review of neurobiology (2024), pp. 251-293
Closed Access

Can epigenetic biomarkers lead us to precision medicine in predicting treatment response and remission for patients being considered for ECT?
Tami Feng, Nagy A. Youssef
Psychiatry Research (2019) Vol. 284, pp. 112659-112659
Closed Access | Times Cited: 3

Genetic Advance in Depressive Disorder
Chen Zhang, Rong Han
Advances in experimental medicine and biology (2019), pp. 19-57
Closed Access | Times Cited: 3

A valepotriate-enriched fraction from Valeriana glechomifolia decreases DNA methylation and up-regulate TrkB receptors in the hippocampus of mice
Liz Girardi Müller, Caroline Biojone, Amanda J. Sales, et al.
Behavioural Pharmacology (2019) Vol. 31, Iss. 4, pp. 333-342
Closed Access | Times Cited: 3

DNA methylation in hearing-related genes in non-syndromic sensorineural hearing loss patients
Oğuz Kadir Eğilmez, Sermet Can, M. Tayyar Kalcıoğlu, et al.
The Egyptian Journal of Otolaryngology (2023) Vol. 39, Iss. 1
Open Access | Times Cited: 1

Molecular Psychiatry: Trends and Study Examples
Theo Rein, Gabriel R. Fries
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 459-459
Open Access | Times Cited: 2

DNA methylation and schizophrenia – the role in pathogenesis and the diagnosis of the disease
Olga Płaza, Agata Szulc
Pharmacotherapy in Psychiatry and Neurology (2022) Vol. 38, Iss. 1, pp. 59-77
Open Access | Times Cited: 1

Family Constellation therapy: A nascent approach for working with non-local consciousness in a therapeutic container
Dan Booth Cohen
Progress in Biophysics and Molecular Biology (2023) Vol. 186, pp. 33-38
Open Access

Commonalities in systemic inflammation, oxidative damage and neurocognition predict telomere length in type 2 diabetes mellitus and severe mental disorders
Rafael Tabarés‐Seisdedos, Joan Vicent Sánchez‐Ortí, Patricia Correa‐Ghisays, et al.
Research Square (Research Square) (2023)
Open Access

Scroll to top